Kinsale Capital Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Kinsale Capital Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $838.80M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $653.47M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $139.33M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $122.50M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $117.71M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $80.35M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $92.80M | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $503.61M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $414.84M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $308.09M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $159.11M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $152.66M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $38.18M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $14.89M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $30.26M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $5.09M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $17.85M | Feb 25, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $976.30M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $859.84M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $557.82M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $407.04M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $279.97M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $178.36M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $103.98M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $77.40M | Mar 2, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.69M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $23.94M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $6.61M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $6.90M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $5.92M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $32.88M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $19.62M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.27M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $179.0K | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $565.0K | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.04B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $4.89B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.77B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.75B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.03B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.55B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.09B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $773.06M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $667.85M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $614.39M | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.08B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $3.40B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.69B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.00B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.33B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $970.66M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $684.67M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $509.08M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $429.66M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $404.18M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.09B | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $745.45M | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $699.34M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $576.24M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $405.88M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $263.99M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $238.19M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $210.21M | Mar 2, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.72B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.23B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $828.25M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $533.12M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $385.94M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $243.32M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $162.91M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $106.55M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $73.50M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $53.64M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $121.04M | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | $77.09M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $100.41M | Feb 25, 2022 |
| FY2021 | Dec 31, 2018 | $75.09M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $81.75M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $50.75M | Mar 2, 2020 |
| FY2018 | Dec 31, 2015 | $24.54M | Feb 28, 2019 |
| FY2017 | Dec 31, 2014 | $23.96M | Mar 1, 2018 |
| FY2016 | Dec 31, 2013 | $16.22M | Mar 16, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $224.40M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $184.12M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $183.85M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $195.75M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $42.70M | Feb 24, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 17 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 17 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23.15M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 23.27M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 23.18M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 23.09M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 22.83M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 22.76M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | 22.21M | Feb 25, 2022 |
| FY2021 | Dec 31, 2018 | 21.24M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | 21.04M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | 20.97M | Mar 2, 2020 |